G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis

被引:140
作者
Cornish, Ann L. [1 ]
Campbell, Ian K. [2 ]
McKenzie, Brent S. [2 ]
Chatfield, Simon [1 ]
Wicks, Ian P. [1 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Parkville, Vic 3052, Australia
[2] Bio21 Inst, CSL, Parkville, Vic, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
COLONY-STIMULATING FACTOR; PULMONARY ALVEOLAR PROTEINOSIS; BLOOD NEUTROPHIL COUNTS; INFLAMMATORY ARTHRITIS; DEFICIENT MICE; APOPTOTIC NEUTROPHILS; ANTIRHEUMATIC DRUGS; OPPOSING ACTIONS; SYNOVIAL-FLUID; EFFECTOR PHASE;
D O I
10.1038/nrrheum.2009.178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are well-recognized regulators of hematopoiesis and have an established role as growth factors in clinical practice. G-CSF and GM-CSF regulate myeloid cell production, differentiation and activation, and might also be important for driving inflammatory responses. Inappropriate engagement of this pathway could be a critical amplification mechanism when maladaptive immune responses predispose to autoimmunity and sterile tissue inflammation. We postulate that antagonism of G-CSF or GM-CSF could represent a novel therapeutic approach for a variety of autoimmune-mediated inflammatory diseases, including rheumatoid arthritis.
引用
收藏
页码:554 / 559
页数:6
相关论文
共 60 条
[1]  
Basu S, 2000, BLOOD, V95, P3725
[2]   Microbial antigen triggers rapid mobilization of TNF-α to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-α production [J].
Bennouna, S ;
Denkers, EY .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4845-4851
[3]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[4]   Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials [J].
Bongartz, T ;
Sutton, AJ ;
Sweeting, MJ ;
Buchan, I ;
Matteson, EL ;
Montori, V .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19) :2275-2285
[5]   Evidence that cytokines play a role in rheumatoid arthritis [J].
Brennan, Fionula M. ;
McInnes, Iain B. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (11) :3537-3545
[6]   Severe inflammatory arthritis and lymphadenopathy in the absence of TNF [J].
Campbell, IK ;
O'Donnell, K ;
Lawlor, KE ;
Wicks, IP .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (12) :1519-1527
[7]  
Carulli G, 1997, HAEMATOLOGICA, V82, P606
[8]  
CHU CQ, 1992, BRIT J RHEUMATOL, V31, P653
[9]   Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease [J].
Cook, AD ;
Braine, EL ;
Campbell, IK ;
Rich, MJ ;
Hamilton, JA .
ARTHRITIS RESEARCH, 2001, 3 (05) :293-298
[10]   NEUTROPHIL KINETICS IN MAN [J].
DANCEY, JT ;
DEUBELBEISS, KA ;
HARKER, LA ;
FINCH, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (03) :705-715